NCT07696065 Palliative Care Integration in Pediatric Oncology Phase 1 Clinical Trials
| NCT ID | NCT07696065 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Phoenix Children's Hospital |
| Condition | Quality of Life Outcomes |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-07-10 |
| Primary Completion | 2028-01-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 30 participants in total. It began in 2026-07-10 with a primary completion date of 2028-01-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Although cure rates continue to rise, one in five children with cancer still die from their disease, so new therapies are urgently needed. Most advances in childhood cancer treatments have originated through clinical trial research and new therapies must be tested in early phase clinical trials. Phase 1 clinical trials are designed to focus mainly on determining whether a drug is safe, and less on how well it cures a disease. These trials may offer patients and families hope when no other options are available to treat their cancer. However, patients in these trials may also experience treatment-related side effects and earlier death. Patients and families enrolled in phase 1 clinical trials often experience increased levels of distress. This distress may result from physical effects of the disease or treatments, or from worry, sadness, or confusion when making difficult decisions related to care or end-of-life. Pediatric palliative care (PPC) is a field that aims to ease physical, psychological, emotional, and spiritual suffering and may be beneficial to patients and families enrolling in phase 1 clinical trials. Over the past decade, PPC has been shown to improve quality of life, patient and family healthcare understanding and satisfaction, communication, shared-medical decision making, advanced care planning, and healthcare cost savings. Despite evidence showing the benefits of PPC, it is not used consistently in pediatric oncology care, particularly in the setting of early phase clinical trials. Including PPC experts is a proven way to improve access to specialty care for vulnerable populations. In this application, investigators propose a study to test the feasibility, acceptability, and potential impact of including PPC consultation for pediatric cancer patients and their families during their enrollment in phase 1 clinical trials.
Eligibility Criteria
Inclusion Criteria: * Patients (aged 0-25 years) diagnosed with cancer and undergoing evaluation for enrollment in a phase 1 trial, their caregivers, as well as their primary treating oncologist are eligible for study participation. Exclusion Criteria: * Previous palliative care exposure
Frequently Asked Questions
Who can join the NCT07696065 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 25 Years, studying Quality of Life Outcomes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT07696065 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT07696065 currently recruiting?
Yes, NCT07696065 is actively recruiting participants. Visit ClinicalTrials.gov or contact Phoenix Children's Hospital to inquire about joining.
Where is the NCT07696065 trial being conducted?
This trial is being conducted at Phoenix, United States, Bethesda, United States, Memphis, United States.
Who is sponsoring the NCT07696065 clinical trial?
NCT07696065 is sponsored by Phoenix Children's Hospital. The trial plans to enroll 30 participants.